{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:42:17Z","timestamp":1790221337584,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100024419","name":"Givaudan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yrtph.2026.106080","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:31:40Z","timestamp":1772782300000},"page":"106080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The regression based defined approach for skin sensitization potency assessment based on NAM data from OECD accepted tests"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2231-2489","authenticated-orcid":false,"given":"Andreas","family":"Natsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2026.106080_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.taap.2010.03.009","article-title":"Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro","volume":"245","author":"Emter","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106080_bib4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/toxsci\/kfh213","article-title":"Development of a peptide reactivity assay for screening contact allergens","volume":"81","author":"Gerberick","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106080_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105244","article-title":"Reference Chemical Potency List (RCPL): a new tool for evaluating the accuracy of skin sensitisation potency measurements by New Approach Methodologies (NAMs)","volume":"134","author":"Irizar","year":"2022","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"11","key":"10.1016\/j.yrtph.2026.106080_bib7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jat.2869","article-title":"Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice","volume":"33","author":"Jaworska","year":"2013","journal-title":"J. Appl. Toxicol."},{"issue":"12","key":"10.1016\/j.yrtph.2026.106080_bib8","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00204-015-1634-2","article-title":"Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy","volume":"89","author":"Jaworska","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106080_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00370734","article-title":"Hydroperoxides in oxidized d-limonene identified as potent contact allergens","volume":"286","author":"Karlberg","year":"1994","journal-title":"Arch. Dermatol. Res."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106080_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.14573\/altex.2302081","article-title":"Integrated skin sensitization assessment based on OECD methods (III): adding human data to the assessment","volume":"40","author":"Natsch","year":"2023","journal-title":"ALTEX"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106080_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tiv.2010.12.014","article-title":"The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study in five laboratories","volume":"25","author":"Natsch","year":"2011","journal-title":"Toxicol. Vitro"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106080_bib13","first-page":"636","article-title":"Integrated skin sensitization assessment based on OECD methods (I): deriving a point of departure for risk assessment","volume":"39","author":"Natsch","year":"2022","journal-title":"ALTEX"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106080_bib14","first-page":"647","article-title":"Integrated skin sensitization assessment based on OECD methods (II): Hazard and potency by combining kinetic peptide reactivity and the \"2 out of 3\" defined approach","volume":"39","author":"Natsch","year":"2022","journal-title":"ALTEX"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106080_bib16","first-page":"652","article-title":"Predictivity of the kinetic direct peptide reactivity assay (kDPRA) for sensitizer potency assessment and GHS subclassification","volume":"37","author":"Natsch","year":"2020","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2026.106080_bib17","series-title":"\"The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins, Part 1: Scientific Evidence.\" OECD ENVIRONMENT, HEALTH AND SAFETY PUBLICATIONS, SERIES ON TESTING AND Assessmen<BNO. 168","year":"2012"},{"key":"10.1016\/j.yrtph.2026.106080_bib18","article-title":"In vitro skin sensitisation assays addressing the key event on activation of dendritic cells on the adverse outcome pathway for skin sensitisation","year":"2018","journal-title":"OECD Guidel. Test. Chem."},{"key":"10.1016\/j.yrtph.2026.106080_bib19","series-title":"Series on Testing and Assessment No. 336","article-title":"Supporting document to the guideline (GL) on defined approaches (DAs) for skin Sensitisation- annex 3","year":"2021"},{"key":"10.1016\/j.yrtph.2026.106080_bib20","article-title":"Test No. 442D: in vitro skin sensitisation: ARE-Nrf2 luciferase test method","year":"2022","journal-title":"OECD Guidel. Test. Chem."},{"key":"10.1016\/j.yrtph.2026.106080_bib21","article-title":"In chemico skin sensitisation assays addressing the adverse outcome pathway, key event on covalent binding to proteins","year":"2023","journal-title":"OECD Guidel. Test. Chem."},{"key":"10.1016\/j.yrtph.2026.106080_bib22","article-title":"Guideline No. 497: defined approaches on skin sensitisation","year":"2025","journal-title":"OECD Guidel. Test. Chem."},{"key":"10.1016\/j.yrtph.2026.106080_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2024.100205","article-title":"The skin allergy risk assessment-integrated chemical environment (SARA-ICE) defined approach to derive points of departure for skin sensitization","volume":"8","author":"Reinke","year":"2025","journal-title":"Curr. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106080_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/tx800431x","article-title":"High throughput kinetic profiling approach for covalent binding to peptides: application to skin sensitization potency of michael acceptor electrophiles","volume":"22","author":"Roberts","year":"2009","journal-title":"Chem. Res. Toxicol."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106080_bib25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.tiv.2005.10.014","article-title":"Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT) II. An inter-laboratory study of the h-CLAT","volume":"20","author":"Sakaguchi","year":"2006","journal-title":"Toxicol. Vitro"},{"issue":"5","key":"10.1016\/j.yrtph.2026.106080_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-0536.2002.460504.x","article-title":"Studies on the autoxidation and sensitizing capacity of the fragrance chemical linalool, identifying a linalool hydroperoxide","volume":"46","author":"Sk\u00f6ld","year":"2002","journal-title":"Contact Dermat."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106080_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/toxics12080536","article-title":"Deriving a continuous point of departure for skin sensitization risk assessment using a bayesian network model","volume":"12","author":"Tourneix","year":"2024","journal-title":"Toxics"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106080_bib28","first-page":"639","article-title":"The kinetic direct peptide reactivity assay (kDPRA): intra- and inter-laboratory reproducibility in a seven-laboratory ring trial","volume":"37","author":"Wareing","year":"2020","journal-title":"ALTEX"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002600053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002600053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:42:38Z","timestamp":1776116558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323002600053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":23,"alternative-id":["S027323002600053X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106080","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The regression based defined approach for skin sensitization potency assessment based on NAM data from OECD accepted tests","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106080"}}